Charles E. Geyer
Magee-Womens Hospital(US)University of Pittsburgh Medical Center(US)
Publications by Year
Research Areas
Breast Cancer Treatment Studies, HER2/EGFR in Cancer Research, Cancer Treatment and Pharmacology, Advanced Breast Cancer Therapies, Estrogen and related hormone effects
Most-Cited Works
- → Trastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer(2005)5,340 cited
- → Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis(2014)4,585 cited
- → Lapatinib plus Capecitabine for HER2-Positive Advanced Breast Cancer(2006)3,443 cited
- → Gene Expression and Benefit of Chemotherapy in Women With Node-Negative, Estrogen Receptor–Positive Breast Cancer(2006)2,562 cited
- → Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer(2018)2,536 cited
- → Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer(2018)2,320 cited
- → Preoperative Chemotherapy: Updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27